Minimal risk of sexual HIV transmission for heterosexual couples when the HIV positive partner has an undetectable viral load
1 February 2013. Related: Conference reports, Women's health, HIV prevention and transmission.
Conference reports
Differences by age for women in response to initial ART: meta-analysis from clinical studies submitted to the FDA
1 February 2013. Related: Conference reports, Antiretrovirals, Women's health.
Lopinavir/ritonavir in pregnancy: results from a systematic review
1 February 2013. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy.
Possible mechanisms for adverse pregnancy outcomes in HIV positive women
1 February 2013. Related: Conference reports, Women's health, Pregnancy.
43rd Union World Conference on Lung Health, 13-17 November 2012, Kuala Lumpur, Malaysia.
1 February 2013. Related: Conference reports.
Paediatric TB: glimpses of PK data and a potential new approach to drug development
1 February 2013. Related: Conference reports, Paediatric care, PK and drug interactions, TB coinfection.
11th International Congress on Drug Therapy in HIV, 11-15 November 2012, Glasgow
1 December 2012. Related: Conference reports.
Issues that divide expert opinion: when to start, HIV and ageing and the impact of HIV on life expectancy
1 December 2012. Related: Conference reports, Ageing and life expectancy.
Dolutegravir: integrase resistance and the impact of the background regimen
1 December 2012. Related: Conference reports, Antiretrovirals.
Updated results on Quad: 96 week data from phase 3 studies
1 December 2012. Related: Conference reports, Antiretrovirals.
HIV/HCV coinfection: early glimpses of an interferon-free future and EuroSIDA incidence data
1 December 2012. Related: Conference reports, Hepatitis coinfection.
Resistance in infants and children receiving ART in South Africa
1 December 2012. Related: Conference reports, Paediatric care.
63rd Annual Meeting of the American Association for the Study of Liver Disease (AASLD), 9-13 November 2012, Boston
1 December 2012. Related: Conference reports.
Cure rates with pipeline HCV drugs: reports from AASLD
1 December 2012. Related: Conference reports, Hepatitis coinfection.
3rd International Workshop on HIV and ageing, 5-6 November 2012, Baltimore
1 December 2012. Related: Conference reports.
BHIVA Autumn Conference, 6-7 October 2012, London
1 December 2012. Related: Conference reports.
52nd International Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 9-12 September 2012, San Francisco
1 October 2012. Related: Conference reports.
Study summaries from ICAAC 2012
1 October 2012. Related: Conference reports, Antiretrovirals, Basic science and immunology.
Antiviral activity in vitro with S/GSK1265744
1 October 2012. Related: Conference reports, Antiretrovirals, Paediatric care.
Efavirenz interaction studies with TB compounds bedaquiline and delamanid
1 October 2012. Related: Conference reports, Antiretrovirals, PK and drug interactions.
19th IAS World AIDS Conference, 22–25 July 2012, Washington
1 October 2012. Related: Conference reports.
HPTN-052: clinical advantages from earlier treatment
1 October 2012. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Hormonal contraception and the risk of HIV acquisition
1 October 2012. Related: Conference reports, Women's health.
Towards an HIV cure: Early developments reported at IAS, part 2
1 October 2012. Related: Conference reports, Cure-related research.
Online video interviews between researchers and activists
1 October 2012. Related: Conference reports, Antiretrovirals, Treatment access, HIV prevention and transmission, Cure-related research, Other news.
19th IAS World AIDS Conference, 22–25 July 2012, Washington
1 August 2012. Related: Conference reports.
IAS: social and political talks online as web casts
1 August 2012. Related: Conference reports, Treatment access, Treatment advocacy.
New booster – cobicistat as an alternative to ritonavir
1 August 2012. Related: Conference reports, Antiretrovirals.
Dolutegravir vs raltegravir in treatment-naive patients: 48 week results from the SPRING 2 study
1 August 2012. Related: Conference reports, Antiretrovirals.
Elvitegravir vs raltegravir: 96 week phase III results in treatment experienced patients
1 August 2012. Related: Conference reports, Antiretrovirals.
In vitro and animal data support safety profile BMS 986001: d4T-like NRTI currently in clinical trials
1 August 2012. Related: Conference reports, Antiretrovirals.
Switching to rilpivirine/tenofovir/FTC fixed dose combination from boosted-PI regimen: SPIRIT study draws the line at 24 weeks
1 August 2012. Related: Conference reports, Antiretrovirals.
Maraviroc plus atazanavir/ritonavir in a nuke-sparing regimen in treatment-naive patients
1 August 2012. Related: Conference reports, Antiretrovirals.
Five-year results from raltegravir registrational studies
1 August 2012. Related: Conference reports, Antiretrovirals.
First report: atazanavir-related gallstones (cholelithiasis)
1 August 2012. Related: Conference reports, Antiretrovirals, Side effects.
Paediatrics studies at 19th International AIDS Conference and the 4th International Workshop on HIV Pediatrics
1 August 2012. Related: Conference reports, Paediatric care.
Novel lopinavir/ritonavir sprinkle formulation for children in resource-limited settings
1 August 2012. Related: Conference reports, Antiretrovirals, Paediatric care.
Update on new antiretrovirals for children and adolescents
1 August 2012. Related: Conference reports, Antiretrovirals, Paediatric care.
Tenofovir prophylaxis for neonates
1 August 2012. Related: Conference reports, Pregnancy, Paediatric care.
Efavirenz levels variable in children in the CHAPAS-3 study
1 August 2012. Related: Conference reports, Antiretrovirals, Paediatric care.
Early initiation of ART is associated with growth recovery in children in NEVEREST-2
1 August 2012. Related: Conference reports, Antiretrovirals, Paediatric care.
High prevalence of peripheral neuropathy in children taking d4T in rural South Africa
1 August 2012. Related: Conference reports, Paediatric care, Side effects.
Lipid profile in children in PREDICT: immediate versus deferred nevirapine-based ART
1 August 2012. Related: Conference reports, Antiretrovirals, Paediatric care.
High levels of maraviroc in rectal tissue fail to protect macaques from SIV transmission following rectal exposure
1 August 2012. Related: Conference reports, HIV prevention and transmission.
Mechanisms for circumcision to reduce HIV transmission in different penile tissue: target cell differences rather than keratinisation
1 August 2012. Related: Conference reports, HIV prevention and transmission.
Towards an HIV cure: early developments reported
1 August 2012. Related: Conference reports, Cure-related research, Basic science and immunology.
Important publications launched at IAS 2012
1 August 2012. Related: Conference reports, Other news.
14th International Workshop on Co-morbidities and Adverse Drug Reactions (IWCADR), 19–21 July 2012, Washington
1 August 2012. Related: Conference reports.
Skeletal muscle toxicity and raltegravir
1 August 2012. Related: Conference reports, Antiretrovirals, Side effects.
Proteinuria as a potential early marker of tenofovir-related renal toxicity
1 August 2012. Related: Conference reports, Side effects.
Earlier and greater comorbidities reported in HIV positive cohort
1 August 2012. Related: Conference reports, Side effects.
20th International HIV Drug Resistance Workshop, 9–13 June 2012, Sitges
1 August 2012. Related: Conference reports.
In vitro resistance profile for BMS 986001
1 August 2012. Related: Conference reports, Drug resistance.
Recombination dynamics in case of MDR sub-type D following superinfection with wild-type sub-type B
1 August 2012. Related: Conference reports, Drug resistance.
Defective viral reservoir populations is common in patients on long-term suppressed ART
1 August 2012. Related: Conference reports, Drug resistance.
First case report of transmission with five-class resistance
1 August 2012. Related: Conference reports, Drug resistance.
New data on the Berlin patient: interpret with caution
1 August 2012. Related: Conference reports, Basic science and immunology, Drug resistance.
18th Annual BHIVA Conference, 18-20 April 2012, UK
1 June 2012. Related: Conference reports.
Half of gay men in London would chose oral PrEP to reduce risk of HIV
1 June 2012. Related: Conference reports, HIV prevention and transmission.
Recent infection is common in UK; 30% gay men aged 15-25 infected within a year of diagnosis
1 June 2012. Related: Conference reports, HIV prevention and transmission.
One third of HIV positive people at five UK clinics have symptomatic depression: link to adherence and viral suppression – 40% cases are untreated
1 June 2012. Related: Conference reports, Side effects, Coinfections and complications.
Hodgkin’s lymphoma: survival normalises to HIV negative rates despite more advanced disease at diagnosis
1 June 2012. Related: Conference reports, Coinfections and complications.
Promising outcomes from laser ablative treatment of AIN2/3 to prevent anal cancer
1 June 2012. Related: Conference reports, Coinfections and complications, Cancer and HIV.
KS in the HAART era includes patients with high CD4 and suppressed viral load: importance of KS chemotherapy for some patients in addition to ART
1 June 2012. Related: Conference reports, Coinfections and complications.
3rd vs 4th generation HIV testing: almost half of UK clinics out of step with national guidelines
1 June 2012. Related: Conference reports, HIV prevention and transmission.